Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
24 08 2023
Historique:
received: 29 11 2022
accepted: 26 07 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

The Acinetobacter baumannii genomic resistance islands (AbGRIs), which were characterized in the genome of the global clone 2 (GC2) A. baumannii contain resistance genes. Here, we aimed to determine the occurrence of AbGRIs in GC2 A. baumannii obtained from COVID-19 patients in a referral hospital in Tehran, Iran. A total of 19 carbapenem-resistant A. baumannii (CRAB) isolates belonging to GC2 and sequence type 2 (ST2), including 17 from COVID-19 patients and two from the devices used in the ICU that the COVID-19 patients were admitted, were examined in this study. Antibiotic susceptibility testing was performed by the disk diffusion method. PCR and PCR mapping, followed by sequencing, were performed to characterize the structure of AbGRI resistance islands in the isolates tested. The AbGRI3 was the most frequent resistance island (RI) detected, present in all the 19 isolates, followed by AbGRI1 (15 isolates; 78.9%) and AbGRI2 (three isolates; 15.8%). Notably, AbGRIs were identified in one of the A. baumannii strains, which was isolated from a medical device used in the ICU where COVID-19 patients were admitted. Furthermore, new structures of AbGRI1 and AbGRI3 resistance islands were found in this study, which was the first report of these structures. The present study provided evidence for the circulation of the GC2 A. baumannii strains harboring AbGRI resistance islands in a referral hospital in Tehran, Iran. It was found that resistance to several classes of antibiotics in the isolates collected from COVID-19 patients is associated with the resistance genes located within AbGRIs.

Identifiants

pubmed: 37620750
doi: 10.1186/s12866-023-02961-3
pii: 10.1186/s12866-023-02961-3
pmc: PMC10464229
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

234

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Biomed Res Int. 2016;2016:2475067
pubmed: 27274985
J Antimicrob Chemother. 2012 Feb;67(2):335-8
pubmed: 22020138
Clin Microbiol Infect. 2021 Jan;27(1):47-54
pubmed: 33190794
J Clin Microbiol. 2002 Aug;40(8):2813-22
pubmed: 12149335
Drug Resist Updat. 2012 Aug;15(4):237-47
pubmed: 22841809
J Antimicrob Chemother. 2021 Jan 1;76(1):65-69
pubmed: 33057672
J Antimicrob Chemother. 2020 Oct 1;75(10):2760-2768
pubmed: 32681170
J Antimicrob Chemother. 2011 Nov;66(11):2484-91
pubmed: 21873287
Front Microbiol. 2022 Jul 22;13:878912
pubmed: 35935207
J Antimicrob Chemother. 2017 Apr 1;72(4):1031-1039
pubmed: 28073968
Microbiol Spectr. 2023 Aug 28;:e0537322
pubmed: 37638730
J Antimicrob Chemother. 2013 Mar;68(3):554-7
pubmed: 23169892
Clin Microbiol Rev. 1996 Apr;9(2):148-65
pubmed: 8964033
Crit Care. 2021 Mar 20;25(1):115
pubmed: 33743812
BMC Infect Dis. 2021 Sep 8;21(1):927
pubmed: 34496774
Infect Control Hosp Epidemiol. 2022 Jun;43(6):815-817
pubmed: 33685542
Int J Antimicrob Agents. 2006 Apr;27(4):351-3
pubmed: 16564159
Front Microbiol. 2023 May 05;14:1172861
pubmed: 37213517
J Antimicrob Chemother. 2016 Sep;71(9):2432-40
pubmed: 27246238
J Antimicrob Chemother. 2022 Feb 2;77(2):345-350
pubmed: 34741594
J Clin Microbiol. 2002 Aug;40(8):3038-40
pubmed: 12149373
Mol Cell Probes. 2001 Aug;15(4):209-15
pubmed: 11513555
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27895018
J Antimicrob Chemother. 2017 Oct 1;72(10):2944-2947
pubmed: 28666372
J Antimicrob Chemother. 2011 Jul;66(7):1504-9
pubmed: 21586593
J Bacteriol. 2006 Aug;188(16):5722-30
pubmed: 16885440
Drug Resist Updat. 2018 Nov;41:26-39
pubmed: 30472242

Auteurs

Ghazal Naderi (G)

Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mahla Asadian (M)

Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Pegah Afarinesh Khaki (PA)

Central Laboratory, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Mohammadreza Salehi (M)

Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Department of infectious diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Alireza Abdollahi (A)

Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. dr_p_abdollahi@yahoo.com.

Masoumeh Douraghi (M)

Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. mdouraghi@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH